InnovAge Holding Corp. (INNV) Form 10-Q — Nov 3, 2026
InnovAge reported fiscal Q1 2027 (quarter ended September 30, 2026) revenue of $264.8 million, up 12.1% year over year, driven by a 6.7% increase in member months and higher Medicaid and Medicare capitation rates. Net income attributable to InnovAge rose 172% to $19.6 million ($0.14 diluted EPS) from $8.0 million a year ago, while Adjusted EBITDA climbed to $31.3 million at an 11.8% margin. Operating cash flow improved sharply to $28.7 million from $3.9 million. The company ended the quarter with $119.3 million in cash, $43.7 million in short-term investments, and $48.2 million of term loan debt, with its revolving credit facility essentially undrawn.
Key figures
- Eps
- 0.14
- Revenue
- 264757000
- Net Income
- 20878000
- Total Debt
- 48179000
- Revenue Yoy
- 12.1%
- Total Assets
- 562964000
- Cash Position
- 119253000
- Shares Outstanding
- 136456506
- Census
- 8420
- Centers
- 20
- Net income yoy
- +172.2%
- Adjusted ebitda
- $31.3M (vs $17.6M prior year)
- Average raf score
- 2.51
- Operating cash flow
- $28.7M (vs $3.9M prior year)
- Total member months
- 25070
- Valuation allowance
- $7.5M (down from $22.4M)
- Prior year net income
- 7669000
- Adjusted ebitda margin
- 11.8%
- Capitation rate increase
- 4.7% Medicaid, 5.8% Medicare
- Revolver capacity remaining
- $92.8M
- Center level contribution margin
- $63.6M (24.0% of revenue)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.